Muscular Dystrophy News Home | Muscular Dystrophy News
WEB6 days ago · Becoming educated and informed about muscular dystrophy is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
Muscular dystrophy patients get first gene therapy - NPR
WEBJun 22, 2023 · Sarepta's muscular dystrophy treatment is the first gene therapy approved under the program. The disease, which almost exclusively affects boys, destroys muscles.
FDA expands approval of first gene therapy for rare form of muscular …
WEBJun 20, 2024 · The US Food and Drug Administration has given the green light for the first gene therapy that treats a rare form of muscular dystrophy to be used in most people who have the disease and a...
FDA approves $3.2 million gene therapy for rare muscular dystrophy …
WEBJun 22, 2023 · The US Food and Drug Administration has approved the first gene therapy to treat a rare and devastating muscle disease but limited the approval to kids ages 4 and 5 based on available evidence ...
Gene therapy for muscular dystrophy stirs hopes and controversy - NPR
WEBMay 2, 2023 · Sarepta's gene therapy for muscular dystrophy would be the first gene therapy approved through the accelerated approval process. And the request has reportedly triggered intense debate within...
The first gene therapy for muscular dystrophy has been …
WEBJun 22, 2023 · The U.S. Food and Drug Administration cleared a shortened version of a gene for a muscle protein to be used in 4- and 5-year-olds with muscular dystrophy.
FDA advisers narrowly vote in favor of experimental gene therapy …
WEBMay 12, 2023 · SRP-9001, an experimental gene therapy that aims to slow or stop the progression of Duchenne muscular dystrophy, is being considered for accelerated approval by the FDA.
‘It’s a vote for hope’: first gene therapy for muscular dystrophy …
WEBJun 2, 2023 · Update: The US Food and Drug Administration has now approved the first gene therapy for Duchenne muscular dystrophy for children aged four and five. The one-time treatment, named Elevidys, will...
FDA Duchenne muscular dystrophy gene therapy : Shots - Health News - NPR
WEBMay 12, 2023 · A panel of experts voted 8-6 in favor of Food and Drug Administration approval of the first gene therapy for Duchenne muscular dystrophy, a fatal genetic disease.
FDA Expands Approval of Gene Therapy for Patients with …
WEBJun 20, 2024 · The FDA expanded the approval of Elevidys, a gene therapy for the treatment of Duchenne muscular dystrophy for ambulatory and non-ambulatory individuals 4 years of age and older with DMD with a...